Onco-Innovations Limited (NEO:ONCO)

Market Cap	36.27M -65.3%
Revenue (ttm)	154.67K
Net Income	-14.26M
EPS	-0.33
Shares Out	57.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,500
Average Volume	31,882
Open	0.6500
Previous Close	0.6300
Day's Range	0.6000 - 0.6500
52-Week Range	0.6000 - 2.3800
Beta	n/a
RSI	31.63
Earnings Date	Mar 17, 2026

About Onco-Innovations

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. Onco-Innovations Limited is headquartered in Calgary, Canada.

• Industry: Biological Products, Except Diagnostic Substances
• CEO: Thomas O’Shaughnessy
• Country: Canada
• Stock Exchange: Cboe Canada
• Ticker Symbol: ONCO